VONTROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vontrol, and when can generic versions of Vontrol launch?
Vontrol is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in VONTROL is diphenidol hydrochloride. There is one drug master file entry for this compound. Additional details are available on the diphenidol hydrochloride profile page.
Summary for VONTROL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 52 |
Patent Applications: | 2,389 |
DailyMed Link: | VONTROL at DailyMed |
US Patents and Regulatory Information for VONTROL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | VONTROL | diphenidol hydrochloride | TABLET;ORAL | 016033-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |